Owkin becomes the latest French unicorn after a $180M investment from Sanofi

Media article at sifted.eu

‍

About Owkin

Owkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to quantify biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.

Press Kit

More like this

In the media

France 24 covers Owkin’s Glioblastoma AI Hackathon

February 4, 2025

In the media

Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit

February 9, 2025